Clinician factors associated with prescribing nicotine replacement therapy in pregnancy: A cross-sectional survey of Australian obstetricians and general practitioners

Yael Bar-Zeev*, Billie Bonevski, Maree Gruppetta, Laura Twyman, Lou Atkins, Kerrin Palazzi, Christopher Oldmeadow, Gillian S. Gould

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

The use of nicotine replacement therapy in pregnancy has been debated but evidence suggests that it is safer than smoking. A cross-sectional survey was conducted with: (i) general practitioners and obstetricians from a college database; and (ii) general practitioners with a special interest in Indigenous health. General practitioners had higher odds of prescribing compared to obstetricians. Reading guidelines, confidence, viewing nicotine replacement therapy as safe, effective and with good adherence, also significantly increased the odds of prescription. Clear guidance regarding safety and efficacy, with practical clinical protocols, are required in order to reduce variation in prescribing rates across these clinicians.

Original languageAmerican English
Pages (from-to)366-370
Number of pages5
JournalAustralian and New Zealand Journal of Obstetrics and Gynaecology
Volume58
Issue number3
DOIs
StatePublished - Jun 2018
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2017 The Royal Australian and New Zealand College of Obstetricians and Gynaecologists

Keywords

  • drug therapy
  • nicotine
  • physicians
  • pregnancy
  • smoking cessation

Fingerprint

Dive into the research topics of 'Clinician factors associated with prescribing nicotine replacement therapy in pregnancy: A cross-sectional survey of Australian obstetricians and general practitioners'. Together they form a unique fingerprint.

Cite this